Nanobiotix (NBTX) Long-Term Investments (2018 - 2025)
Nanobiotix's (NBTX) quarterly Long-Term Investments came in at $505194.9 in Q4 2025, up 16.44% year-on-year from $433849.7 in Q4 2024, and up 9.12% quarter-over-quarter from $462971.5 in Q2 2025.
Nanobiotix (NBTX) Long-Term Investments (2018 - 2025) Analysis & Trends
Nanobiotix's Long-Term Investments history runs 8 years deep, the most recent figure standing at $505194.9 for Q4 2025.
- On a quarterly basis, Long-Term Investments rose 16.44% year-over-year to $505194.9 in Q4 2025; TTM through Dec 2025 was $505194.9, a 16.44% increase from a year earlier, with the FY2025 full-year figure at $490338.1, up 13.02% from the prior year.
- Long-Term Investments rose to $505194.9 in Q4 2025 per NBTX's latest filing, from $462971.5 in the prior quarter.
- Across five years, Long-Term Investments topped out at $599727.2 in Q2 2021 and bottomed at $296892.0 in Q4 2022.
- The 5-year median for Long-Term Investments is $404726.8 (2022), against an average of $424149.1.
- Across the five-year window, Long-Term Investments slumped 49.99% in 2022 and soared 39.58% in 2025, its largest moves.
- Year by year, Long-Term Investments stood at $593720.9 in 2021, then tumbled by 49.99% to $296892.0 in 2022, then increased by 8.36% to $321706.0 in 2023, then surged by 34.86% to $433849.7 in 2024, then rose by 16.44% to $505194.9 in 2025.
- Per Business Quant, the three latest NBTX Long-Term Investments figures stand at $505194.9 (Q4 2025), $462971.5 (Q2 2025), and $433849.7 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 22.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 505,194.89 |
| Jun 30, 2025 | 462,971.51 |
| Dec 31, 2024 | 433,849.73 |
| Jun 30, 2024 | 331,681.37 |
| Dec 31, 2023 | 321,706.03 |
| Jun 30, 2023 | 320,143.77 |
| Dec 31, 2022 | 296,891.98 |
| Jun 30, 2022 | 375,603.95 |
| Dec 31, 2021 | 593,720.92 |
| Jun 30, 2021 | 599,727.18 |
| Dec 31, 2020 | 602,106.37 |
| Dec 31, 2019 | 585,543.58 |
| Dec 31, 2018 | 636,899.21 |